CROS NT has a strong CRO management team with a wealth of experience in the life sciences and clinical trials sector.

Paolo Morelli, CEO CROS NT

Paolo Morelli - CEO of PM Holding, CROS NT, Arithmos, seQure

Paolo is a passionate entrepreneur who has over 19 years of experience in the Life Sciences industry. He is involved as a scientific advisor in multiple technology innovation start-ups and is a member of leading industry associations.

Paolo’s goal as CEO of PMH is to continue investing in new technologies such as Artificial Intelligence, Machine Learning, Internet of Things and digital health. He is committed to contributing to the transformation of clinical trials through technology to support the delivery of treatments to patients faster, safer, and more cost-effective.

Linkedin
Giorgio Jones_Second Version

Giorgio Jones - Chief Financial Officer and HR Director of PM Holding

Giorgio has over 28 years of experience in the pharmaceutical industry with 25 years of this spent in the CRO sector in key roles such as European Financial Controller, Finance and HR Director, and CFO. He is a Chartered Management Accountant and a Chartered Member of the Institute of Personnel and Development. Giorgio is an energetic leader and experienced professional; he is the driving force behind CROS NT employee-centric culture and company values.

Linkedin
Angela Weston

Angela Weston - Chief Commercial Officer of PM Holding

Angela brings a wealth of experience in business development, marketing and proposal management at a global level for companies in pharmaceutical, medical device and CRO. She started her career in Healthcare before moving into Sales serving as Director of Business Development and SVP Business Development for some of the biggest players on the international Life Sciences market.

Under Angela’s direction, her team is implementing infrastructure to support effective business development and marketing strategies to enable continued company growth.

Linkedin
Andrea Pulvirenti_sent

Andrea Pulvirenti
Managing Director

Andrea started as a Project Manager for CROS NT in 2011 and was appointed as Managing Director in 2018 after holding a variety of roles in the company. He is a natural leader who strives for continuous process improvement and long-term success. Andrea possesses a degree in Engineering from Università degli Studi di Brescia (Brescia, Italy) and Executive Master’s degrees in Project Management, Corporate Finance and Business Administration (MBA). He also holds Project Management Professional (PMP) certification accredited by Project Management Institute.

Linkedin
Fabio Gambini_sent

Fabio Gambini
Chief Medical Officer

Fabio is an accomplished leader with over 25 years of experience in the pharmaceutical industry. He began his career in GSK as Pre-clinical Scientist and later moved to the Medical Department where he took a role of Clinical Research Physician. In 2006, Fabio joined Amgen as Regional Medical Affairs Manager for the Oncology division later becoming Nephrology Therapeutic Area Leader & Development Operation Manager.

Prior to joining CROS NT, Fabio held the position of Onco-Haematology Medical Director at Roche, Corporate Medical Director and Market Access at Zambon Group, and Medical Director at Alexion Pharmaceuticals.

Fabio possesses a Medical Degree from Università degli Studi di Verona (Verona, Italy) and an MBA from SDA Bocconi School of Management (Milan, Italy).

Linkedin
Vesna Stamenkovic_sent

Vesna Stamenkovic
Director of Business Development

Vesna joined CROS NT in 2013 as a Business Development Account Manager. Her role progressed to Business Development Director for Europe and in 2018, Vesna stepped into the role of VP of global business development  for CROS NT. Vesna excels when building client-oriented teams ready to support Life Sciences companies in pre- and post-market studies across a wide range of solutions and therapeutic areas

Vesna holds a pharmacy degree from Università degli Studi di Genova (Genova, Italy) and University of Belgrade (Serbia) and began her career with some of the world’s largest pharmaceutical companies including GlaxoSmithKline and Pfizer.

Linkedin
Sebastien Gerin

Sébastien Gerin
Chief Operating Officer

Sébastien has a pivotal role in CROS NT as he oversees all of CROS NT’s global operations throughout Europe, North America and India. He has spent 20 years in the drug development industry before joining CROS NT. He worked on both the Sponsor and CRO side including 14 years with Merck Serono where he was global Head of Global Statistical Programming.

Experienced professional, Sébastien understands data and its importance and power to the success of clinical research. He holds a Statistics and Data Processing Degree from Université Grenoble Alpes (Grenoble, France).

Linkedin